Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115


Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.

Chlenski A, Guerrero LJ, Peddinti R, Spitz JA, Leonhardt PT, Yang Q, Tian Y, Salwen HR, Cohn SL.

Mol Cancer. 2010 Jun 4;9:138. doi: 10.1186/1476-4598-9-138.


SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.

Chlenski A, Liu S, Crawford SE, Volpert OV, DeVries GH, Evangelista A, Yang Q, Salwen HR, Farrer R, Bray J, Cohn SL.

Cancer Res. 2002 Dec 15;62(24):7357-63.


Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.

Yang Q, Tian Y, Liu S, Zeine R, Chlenski A, Salwen HR, Henkin J, Cohn SL.

Cancer Res. 2007 Feb 15;67(4):1716-24.


Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.

Pastorino F, Brignole C, Marimpietri D, Cilli M, Gambini C, Ribatti D, Longhi R, Allen TM, Corti A, Ponzoni M.

Cancer Res. 2003 Nov 1;63(21):7400-9.


Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.

Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.

Chin Med J (Engl). 2008 Nov 20;121(22):2324-30.


Notch signaling regulates tumor-induced angiogenesis in SPARC-overexpressed neuroblastoma.

Gorantla B, Bhoopathi P, Chetty C, Gogineni VR, Sailaja GS, Gondi CS, Rao JS.

Angiogenesis. 2013 Jan;16(1):85-100. doi: 10.1007/s10456-012-9301-1. Epub 2012 Sep 6.


SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.

Chlenski A, Liu S, Guerrero LJ, Yang Q, Tian Y, Salwen HR, Zage P, Cohn SL.

Int J Cancer. 2006 Jan 15;118(2):310-6.


The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.

Bäckman U, Svensson A, Christofferson RH, Azarbayjani F.

Anticancer Res. 2008 May-Jun;28(3A):1551-7.


Angiogenesis can be reduced without significant reduction of tumor growth.

Svensson A, Bäckman U, Fuchs D, Christofferson R, Azarbayjani F.

Anticancer Res. 2007 Nov-Dec;27(6B):3883-9.


Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.

Kakodkar NC, Peddinti RR, Tian Y, Guerrero LJ, Chlenski A, Yang Q, Salwen HR, Maitland ML, Cohn SL.

Pediatr Blood Cancer. 2012 Oct;59(4):642-7. doi: 10.1002/pbc.24004. Epub 2011 Dec 6.


Antiangiogenic therapy inhibits human neuroblastoma growth.

Katzenstein HM, Salwen HR, Nguyen NN, Meitar D, Cohn SL.

Med Pediatr Oncol. 2001 Jan;36(1):190-3.


Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma.

Kaicker S, McCrudden KW, Beck L, New T, Huang J, Frischer JS, Serur A, Kadenhe-Chiweshe A, Yokoi A, Kandel JJ, Yamashiro DJ.

Int J Oncol. 2003 Dec;23(6):1651-5.


Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.

Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.

Cancer Res. 2002 Dec 1;62(23):6884-90.


Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.

Brignole C, Marimpietri D, Pastorino F, Nico B, Di Paolo D, Cioni M, Piccardi F, Cilli M, Pezzolo A, Corrias MV, Pistoia V, Ribatti D, Pagnan G, Ponzoni M.

J Natl Cancer Inst. 2006 Aug 16;98(16):1142-57.


Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.

Vajkoczy P, Menger MD, Goldbrunner R, Ge S, Fong TA, Vollmar B, Schilling L, Ullrich A, Hirth KP, Tonn JC, Schmiedek P, Rempel SA.

Int J Cancer. 2000 Jul 15;87(2):261-8.


Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.

Pastorino F, Di Paolo D, Loi M, Becherini P, Caffa I, Zorzoli A, Marimpietri D, Carosio R, Perri P, Montaldo PG, Brignole C, Pagnan G, Ribatti D, Allen TM, Ponzoni M.

Curr Drug Targets. 2009 Oct;10(10):1021-7. Review.


Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells.

Michaelis M, Klassert D, Barth S, Suhan T, Breitling R, Mayer B, Hinsch N, Doerr HW, Cinatl J, Cinatl J Jr.

Mol Cancer. 2009 Sep 29;8:80. doi: 10.1186/1476-4598-8-80.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk